Pricing Log in Create free account

Can-Fite Biopharma Ltd (CANF) vs Creative Medical Technology Holdings, Inc. (CELZ)

Can-Fite Biopharma Ltd and Creative Medical Technology Holdings, Inc. are both Biotechnology companies. Can-Fite Biopharma Ltd and Creative Medical Technology Holdings, Inc. are of similar size ($5.6M and $5.4M). Can-Fite Biopharma Ltd grew revenue faster over the last twelve months: −3.36% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −1,148.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Can-Fite Biopharma Ltd leads on 9 and Creative Medical Technology Holdings, Inc. on 6.

Valuation

Metric CANF CELZ Biotechnology median
P/E n/m n/m 8.50
P/S 0.45 161.13 9.71
P/B 0.07 0.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.58 0.98 0.64
EV/Sales (8.64) (351.86) 9.21
Earnings yield (738.94%) (279.73%) (33.15%)
Free cash flow yield (5,538.69%) (409.71%) (25.50%)

Profitability

Metric CANF CELZ Biotechnology median
Gross margin 0.00% 61.18% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,148.62%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (77.91%) (56.36%)
Return on assets 0.00% (73.30%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CANF CELZ Biotechnology median
Revenue growth (TTM) (3.36%) (79.42%) 6.02%
EPS growth (last fiscal year) 45.23% 32.08% 30.26%
Revenue growth, 5-year CAGR (11.90%) (48.43%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CANF CELZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.60 12.91 4.72
Net debt to EBITDA 0.86 1.20 0.96

Dividend

Metric CANF CELZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CANF CELZ Biotechnology median
Market cap 5.61m 5.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack